SPBC9B6.11c Antibody

What is SPBC9B6.11c and why is it significant for research?

SPBC9B6.11c is a gene/protein identifier in Schizosaccharomyces pombe (fission yeast). This protein is cataloged in major databases including KEGG (spo:SPBC9B6.11c) and STRING (4896.SPBC9B6.11c.1) . The significance of this protein in research stems from S. pombe's status as an important model organism in molecular and cellular biology. Antibodies against SPBC9B6.11c enable researchers to investigate protein localization, expression levels, protein-protein interactions, and functional studies within yeast cellular systems. When selecting an antibody for SPBC9B6.11c research, consider application compatibility, species reactivity, and validation evidence to ensure reliable experimental outcomes.

What applications are typically used with SPBC9B6.11c antibodies in yeast research?

SPBC9B6.11c antibodies can be employed across multiple research applications similar to other yeast protein antibodies:

When working with yeast proteins like SPBC9B6.11c, cell wall disruption efficiency is a critical methodological consideration that directly impacts antibody accessibility to target proteins . For optimal results in immunofluorescence applications, use freshly prepared paraformaldehyde fixation (4%) followed by controlled cell wall digestion to maintain both cellular architecture and epitope integrity.

How should I optimize antibody concentration for SPBC9B6.11c detection in Western blots?

Optimizing antibody concentration for SPBC9B6.11c detection requires systematic titration. Begin with a concentration range of 0.5-5 μg/ml based on similar antibody applications . The titration protocol should include:

• Prepare serial dilutions of the antibody (e.g., 0.5, 1, 2, and 5 μg/ml)

• Run identical yeast lysate samples on multiple lanes

• Process membranes with different antibody concentrations

• Evaluate signal-to-noise ratio for each concentration

For secondary antibody selection, conjugated systems like Alexa Fluor® used at 1:1000-1:2000 dilutions typically provide optimal detection sensitivity with minimal background . Remember that yeast proteins often require longer blocking times (2 hours minimum) with 5% BSA or milk to reduce non-specific binding. The optimal antibody concentration should provide clear band detection at the expected molecular weight with minimal background signal.

What are the most effective lysis methods for S. pombe when preparing samples for SPBC9B6.11c immunodetection?

Effective lysis of S. pombe for SPBC9B6.11c immunodetection requires specialized approaches to disrupt the rigid yeast cell wall while preserving protein epitopes. The comparative effectiveness of common lysis methods is summarized below:

The glass bead disruption method typically yields the best results for whole-cell protein extraction. The protocol should include:

• Harvest yeast cells in log phase (OD600 = 0.5-1.0)

• Resuspend cell pellet in lysis buffer containing protease inhibitors

• Add acid-washed glass beads (0.5mm diameter)

• Vortex vigorously in 30-second intervals with cooling on ice between cycles

• Centrifuge to remove cell debris and collect the protein-containing supernatant

This approach maximizes protein yield while minimizing protein degradation that could affect antibody recognition of SPBC9B6.11c . For phosphorylated protein variants, include phosphatase inhibitors in all buffers to preserve post-translational modifications.

How should I optimize fixation and permeabilization for SPBC9B6.11c immunofluorescence studies?

For immunofluorescence detection of SPBC9B6.11c in S. pombe, specific fixation and permeabilization protocols must be optimized to enable antibody penetration through the yeast cell wall while preserving cellular architecture:

• Fixation optimization:

  • 4% paraformaldehyde (15-20 minutes) preserves most epitopes while maintaining cellular structure

  • Methanol fixation (-20°C, 6 minutes) may provide better accessibility but can denature some epitopes

  • For dual fixation, begin with 3.7% formaldehyde (10 minutes) followed by 100% methanol (6 minutes at -20°C)

• Permeabilization strategies:

  • Enzymatic: Treat with zymolyase (1mg/ml, 30 minutes at 37°C) to digest cell wall components

  • Chemical: Use 0.1% Triton X-100 after enzymatic treatment for complete membrane permeabilization

Based on protocols for similar yeast proteins, enzymatic digestion followed by mild detergent treatment provides optimal antibody accessibility while preserving subcellular structures . Monitoring cell wall digestion microscopically helps prevent over-digestion that could compromise cellular morphology. This balanced approach ensures specific signal detection while maintaining the spatial context necessary for accurate localization studies.

How can I validate SPBC9B6.11c antibody specificity in S. pombe experiments?

Validating SPBC9B6.11c antibody specificity requires multiple complementary approaches to confirm true target recognition:

A rigorous validation protocol should include at least two complementary methods. For genetic validation, use CRISPR/Cas9 or homologous recombination to create SPBC9B6.11c deletion strains, then perform Western blot analysis comparing wild-type and knockout samples. The antibody should show a clear band at the expected molecular weight in wild-type samples that is absent in knockout samples . For peptide competition, pre-incubate the antibody with 5-10 fold molar excess of the immunizing peptide before application to samples, which should abolish specific signal while non-specific binding would remain.

What controls should be included when using SPBC9B6.11c antibodies in co-immunoprecipitation studies?

Comprehensive controls are essential for reliable co-immunoprecipitation (co-IP) studies with SPBC9B6.11c antibodies:

• Essential negative controls:

  • Non-specific IgG from the same species as the SPBC9B6.11c antibody

  • Lysate-only (no antibody) to detect non-specific binding to beads

  • If available, lysate from SPBC9B6.11c deletion strain

• Validation controls:

  • Input sample (pre-IP lysate, typically 5-10%)

  • Unbound fraction to assess IP efficiency

  • Known interacting partner detection (if established)

• Technical controls:

  • RNase/DNase treatment to eliminate nucleic acid-mediated interactions

  • Crosslinking efficiency validation (if using crosslinking approaches)

For quantitative analysis, include serial dilutions of input samples (100%, 50%, 25%, 10%) to establish a standard curve for semi-quantitative assessment of pull-down efficiency . When analyzing novel interactions, reciprocal co-IPs (using antibodies against the potential interacting partner) provide stronger evidence of true protein-protein interactions.

How can I optimize ChIP protocols for SPBC9B6.11c if it functions as a DNA-binding protein?

If SPBC9B6.11c functions as a DNA-binding protein, optimizing Chromatin Immunoprecipitation (ChIP) protocols requires specific adaptations for yeast systems:

For S. pombe ChIP experiments, cell wall disruption efficiency directly impacts chromatin accessibility and immunoprecipitation yield. Optimize sonication conditions specifically for yeast cells by testing different cycle numbers (18-30 cycles) and amplitudes to achieve DNA fragments of 200-500bp . For antibody incubation, longer incubation times (16-20 hours) with gentle rotation at 4°C typically improve chromatin immunoprecipitation efficiency in yeast systems.

What approaches can resolve discrepancies between SPBC9B6.11c protein expression and localization data?

When facing discrepancies between protein expression and localization data for SPBC9B6.11c, a systematic troubleshooting approach is necessary:

• Epitope accessibility analysis:

  • Test multiple antibodies targeting different epitopes of SPBC9B6.11c

  • Compare native vs. denatured detection methods

  • Evaluate fixation impact on epitope recognition

• Cell cycle-dependent variation:

  • Synchronize cells and analyze expression/localization at defined cell cycle stages

  • Quantify protein levels using Western blot with loading controls

  • Track localization changes using time-lapse microscopy with tagged SPBC9B6.11c

• Post-translational modification effects:

  • Use phospho-specific antibodies if phosphorylation is suspected

  • Treat samples with phosphatase inhibitors vs. phosphatase treatment

  • Employ mass spectrometry to identify modifications affecting antibody recognition

When different detection methods yield conflicting results, combining fluorescent protein tagging (N- and C-terminal) with antibody-based detection can help resolve discrepancies . For comprehensive analysis, use quantitative Western blots to measure total protein levels while employing high-resolution microscopy to assess localization patterns across different physiological conditions and genetic backgrounds.

How can SPBC9B6.11c antibodies be utilized in high-throughput screening applications?

SPBC9B6.11c antibodies can be adapted for high-throughput screening applications through several specialized techniques:

For implementation in automated systems, antibody concentration and incubation parameters must be rigorously standardized. Develop a high-throughput immunofluorescence protocol by:

• Optimizing cell fixation in 96-well or 384-well plate formats

• Establishing automated permeabilization and washing steps

• Determining minimum effective antibody concentration

• Standardizing image acquisition parameters for consistent quantification

When adapting SPBC9B6.11c antibodies for high-content screening, validate signal-to-noise ratios across the entire plate to account for positional effects . Automated image analysis should include cell segmentation, background correction, and multi-parametric feature extraction to quantify both expression levels and subcellular distribution patterns.

What are common causes of non-specific binding with SPBC9B6.11c antibodies and how can they be mitigated?

Non-specific binding with SPBC9B6.11c antibodies can arise from multiple sources, each requiring specific mitigation strategies:

To systematically reduce non-specific binding, implement a sequential optimization approach:

• Increase blocking stringency by using 5% BSA with 0.1% Tween-20 for 2 hours at room temperature

• Perform antibody dilution in blocking buffer containing 1% of the blocking agent

• Add 0.1-0.5M NaCl to antibody dilution buffer to increase stringency

• Include 0.1% Triton X-100 in wash buffers and increase washing duration and frequency

For Western blot applications specifically, cutting membranes to incubate the target molecular weight region separately can minimize background when combined with overnight primary antibody incubation at 4°C . When troubleshooting immunofluorescence applications, sequential primary antibody incubation rather than cocktail application often improves signal specificity.

How should I address weak or variable signal issues when detecting SPBC9B6.11c in different experimental conditions?

Addressing weak or variable SPBC9B6.11c detection signals requires systematic optimization of multiple experimental parameters:

• Sample preparation enhancement:

  • Include protease inhibitor cocktails during all preparation steps

  • Minimize freeze-thaw cycles of samples and antibody solutions

  • For low-abundance proteins, consider concentration methods (TCA precipitation)

• Signal amplification strategies:

  • Implement tyramide signal amplification for immunocytochemistry

  • Use high-sensitivity ECL substrates for Western blot

  • Consider biotin-streptavidin systems for signal enhancement

• Antibody incubation optimization:

  • Extend primary antibody incubation to overnight at 4°C

  • Test different antibody diluents (BSA vs. milk vs. commercial formulations)

  • Optimize incubation temperature (4°C vs. room temperature)

A structured approach to troubleshooting involves preparing a standardized positive control sample that can be included in each experiment to normalize for day-to-day variations . For quantitative applications, generate a standard curve with known quantities of recombinant protein to calibrate detection sensitivity across experimental conditions.

How can SPBC9B6.11c antibodies be adapted for super-resolution microscopy in yeast cells?

Adapting SPBC9B6.11c antibodies for super-resolution microscopy in yeast requires specific modifications to standard immunofluorescence protocols:

For optimal results in structured illumination microscopy (SIM), use Alexa Fluor® 488 or Alexa Fluor® 594 conjugated secondary antibodies as these demonstrate excellent brightness and photostability . Cell wall digestion must be carefully optimized for super-resolution applications—excessive digestion compromises ultrastructure while insufficient digestion limits antibody penetration and creates artifacts.

A specialized protocol for STORM imaging would include:

• Treating fixed cells with higher concentration zymolyase (2-3mg/ml) for controlled cell wall digestion

• Using 0.2% Triton X-100 for enhanced permeabilization

• Extending antibody incubation times (primary: overnight at 4°C; secondary: 4 hours at room temperature)

• Including oxygen scavenging system and appropriate switching buffer during imaging

What considerations are important when using SPBC9B6.11c antibodies in combination with multi-omics approaches?

Integrating SPBC9B6.11c antibody-based techniques with multi-omics approaches requires careful experimental design to ensure compatible sample processing and data integration:

When designing integrated experiments, consider these critical factors:

• Sample partitioning strategy:

  • Develop protocols that allow sample splitting for parallel omics analyses

  • Ensure fixation/extraction methods are compatible with multiple downstream applications

  • Establish normalization standards across different analytical platforms

• Temporal coordination:

  • For time-series experiments, synchronize sampling across all platforms

  • Consider stability differences between molecules (proteins vs. RNA vs. metabolites)

  • Account for different processing timeframes required for each method

• Data integration frameworks:

  • Establish common identifiers across datasets

  • Develop computational pipelines for multi-modal data visualization

  • Implement statistical methods appropriate for heterogeneous data types

For optimal integration of antibody-based assays with transcript analysis, consider dual RNA-FISH/immunofluorescence protocols that allow simultaneous visualization of SPBC9B6.11c protein localization and mRNA distribution . This approach provides direct correlation between expression and localization at the single-cell level, enabling identification of post-transcriptional regulatory mechanisms.